Interaction of S-sulfonated human IgG with human complement and its components. 1977

Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe

S-sulfonated human IgG (S-sIgG) was prepared by treating IgG with sodium sulfite and sodium tetrathionate. The treatment resulted in the selective cleavage of interchain disulfide bonds of the IgG to give S-sulfonate groups. Complement fixing activities of aggregated S-sIgG and the immune complex formed with the S-sIgG antibody were very weak. S-sIgG at a high dose reduced the activity of the first complement component (C1) in normal human serum without any reduction of other complement components activites, but S-alkylated IgG at the same dose did not. Loss of C1 activity was not caused by either S-sulfonated myeloma proteins (IgA and IgE) or urea-treated S-sIgG, in which both inter- and intra-chain disulfide bonds were cleaved. These results suggest that the selective reduction of C1 by S-sIgG is due to a conformational change of the immunoglobulin.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D010434 Pepsin A Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice. Pepsin,Pepsin 1,Pepsin 3
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013451 Sulfonic Acids Inorganic or organic oxy acids of sulfur which contain the RSO2(OH) radical. Sulfonic Acid,Acid, Sulfonic,Acids, Sulfonic

Related Publications

Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
March 1949, The Journal of clinical investigation,
Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
December 2004, Iranian journal of allergy, asthma, and immunology,
Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
July 1992, European journal of immunology,
Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
August 1973, Immunochemistry,
Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
January 1986, Canadian journal of microbiology,
Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
December 2019, Molecular immunology,
Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
March 1983, Harefuah,
Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
September 1982, Biology of reproduction,
Y Fukumoto, and S Inai, and K Nagaki, and K Iida, and E Yamagami, and Y Masuho, and T Watanabe
June 1991, Sangre,
Copied contents to your clipboard!